Compare Illumina, Inc. (ILMN) vs Weibo Corp (WB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Weibo Corp — how do they compare? Illumina, Inc. trades at $189.78 (market cap $27.94B), while Weibo Corp trades at $8 (market cap $1.95B). The key difference: Illumina, Inc. is far larger — about 14.3× Weibo Corp's market cap, and Weibo Corp pays a 7.63% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | WB | |
|---|---|---|
Market Cap | $27.94B | $1.95B |
Sector | Health | Media |
52-Week High | $194.33 | $12.83 |
52-Week Low | $91.00 | $7.20 |
Enterprise Value | $29.33B | $1.22B |
Dividend Yield | — | 7.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
Weibo (WB) trades at $7.995, up 3.16% today, with a bullish technical signal from moving averages but overbought RSI readings. The stock shows deep value with a P/E of 5.42 and P/B of 0.49, supported by strong profitability including a 21.15% net margin. Recent earnings have slightly missed expectations, but revenue remains stable at $1.76 billion for 2025. News highlights Weibo's cash flow generation and inclusion in value stock lists, though competitive pressures are noted.
The outlook balances significant undervaluation against competitive and execution risks. The market cap of approximately $1.8 billion is below the net balance sheet value, suggesting a margin of safety. Key risks include user engagement challenges from rivals like Douyin and reliance on advertising revenue. Analyst sentiment is mixed but leans positive, with 45% recommending Buy. The stock presents a value opportunity contingent on successful business execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Weibo Corp
Weibo is the largest social media platform in China. As of 2020, Weibo had 521 million monthly active users and 225 million daily active users, many of whom are drawn there by the millions of key opinion leaders in entertainment, sports, and business circles. Sina is the major shareholder, holding 44.7% of shares and with 70.8% voting power.
Read more on WB →
